Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
07:36pm, Thursday, 03'rd Nov 2022
Cerus (CERS) delivered earnings and revenue surprises of 0% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cerus Corporation (CERS) Q3 2022 Earnings Call Transcript
05:50pm, Thursday, 03'rd Nov 2022
Cerus Corporation (NASDAQ:CERS ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jessica Hanover - Vice President, Corporate Affairs Obi Greenman - President and Chie
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
08:30am, Thursday, 20'th Oct 2022
CONCORD, Calif.
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
07:10am, Wednesday, 19'th Oct 2022 Seeking Alpha
ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for Cerus (CERS)
01:35pm, Wednesday, 21'st Sep 2022 Zacks Investment Research
Cerus (CERS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for Cerus (CERS)
11:17am, Wednesday, 21'st Sep 2022
Cerus (CERS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
10:20am, Thursday, 15'th Sep 2022 Zacks Investment Research
Sector ETF report for XHE
Zimmer (ZBH) Surges 4.2%: Is This an Indication of Further Gains?
03:17pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Zimmer (ZBH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Down 20.4% in 4 Weeks, Here's Why Cerus (CERS) Looks Ripe for a Turnaround
01:35pm, Monday, 29'th Aug 2022 Zacks Investment Research
Cerus (CERS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates cou
Down 20.4% in 4 Weeks, Here's Why Cerus (CERS) Looks Ripe for a Turnaround
12:03pm, Monday, 29'th Aug 2022
Cerus (CERS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates cou
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks
11:58am, Wednesday, 24'th Aug 2022 The Motley Fool
This billionaire-guided hedge fund went bargain-shopping in the second quarter.
Cerus (CERS) Q2 2022 Earnings Call Transcript
05:00pm, Friday, 05'th Aug 2022 The Motley Fool
CERS earnings call for the period ending June 30, 2022.
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
09:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Cerus (CERS) delivered earnings and revenue surprises of 16.67% and 2.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Thursday, 04'th Aug 2022
Cerus (CERS) delivered earnings and revenue surprises of 16.67% and 2.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Cerus Corporation's (CERS) CEO Obi Greenman on Q2 2022 Results - Earnings Call Transcript
06:31pm, Thursday, 04'th Aug 2022
Cerus Corporation (NASDAQ:CERS ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Matt Notarianni - Senior Director-Investor Relations Obi Greenman - President and Chief
